The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics

Cannabis use and cannabis use disorder

(2021) Jason P. Connor et al.   Nature Reviews Disease Primers

Fatty acid amide hydrolase binding is inversely correlated with amygdalar functional connectivity: a combined positron emission tomography and magnetic resonance imaging study in healthy individuals

(2021) Duncan G.J. Green et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Fear extinction learning and anandamide: an fMRI study in healthy humans

(2021) Jennifer Spohrs et al.   Translational Psychiatry

2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics

(2020) Gaurav Bedse et al.   BIOLOGICAL PSYCHIATRY

A Guide to Targeting the Endocannabinoid System in Drug Design

(2020) Adam Stasiulewicz et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cannabinoids and Cannabinoid Receptors: The Story so Far

(2020) Fred Shahbazi et al.   iScience

Understanding the Emergence of Social Anxiety in Children with Behavioral Inhibition

(2020) Nathan A. Fox et al.   BIOLOGICAL PSYCHIATRY

The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study

(2020) Mark E. Schmidt et al.   NEUROPSYCHOPHARMACOLOGY

Hemogram parameters in childhood anxiety disorders: Could anxiety disorders be related with inflammation?

(2020) Necati Uzun et al.   MEDICAL HYPOTHESES

The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: a randomized clinical trial

(2020) Martin P. Paulus et al.   NEUROPSYCHOPHARMACOLOGY

Unidirectional opioid-cannabinoid cross-tolerance in the modulation of social play behavior in rats

(2019) Sara Schiavi et al.   PSYCHOPHARMACOLOGY

Microdeletion in a pseudogene identified in a patient with high anandamide concentrations and pain insensitivity

(2019) Abdella M. Habib et al.   BRITISH JOURNAL OF ANAESTHESIA

CB1 receptor antagonism in capuchin monkeys alters social interaction and aversive memory extinction

(2019) Natália Gonczarowska et al.   PSYCHOPHARMACOLOGY

Endocannabinoid and Prostanoid Crosstalk in Pain

(2019) Baptiste Buisseret et al.   TRENDS IN MOLECULAR MEDICINE

Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial

(2019) Leah M. Mayo et al.   BIOLOGICAL PSYCHIATRY

Cortico-Limbic Interactions Mediate Adaptive and Maladaptive Responses Relevant to Psychopathology

(2019) Rothem Kovner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study

(2019) Olof R. Hjorth et al.   MOLECULAR PSYCHIATRY

Sex specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signaling

(2018) Francesca Melancia et al.   BRITISH JOURNAL OF PHARMACOLOGY

Enduring effects of psychological treatments for anxiety disorders: meta-analysis of follow-up studies

(2018) Borwin Bandelow et al.   BRITISH JOURNAL OF PSYCHIATRY

Endocannabinoid system, Stress and HPA axis

(2018) Vincenzo Micale et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release

(2018) Alexandre Seillier et al.   NEUROPHARMACOLOGY

The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling

(2018) Manoela V. Fogaça et al.   NEUROPHARMACOLOGY

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation

(2018) Yatendra Mulpuri et al.   NEUROPHARMACOLOGY

Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors

(2018) Gaurav Bedse et al.   Translational Psychiatry

Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders

(2018) Ewgeni Jakubovski et al.   DEPRESSION AND ANXIETY

Nuclear Neuroimaging in Social Anxiety Disorder: A Review

(2018) Alexander G. Doruyter et al.   JOURNAL OF NUCLEAR MEDICINE

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test

(2018) Ila M. Linares et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol

(2017) Douglas L Boggs et al.   NEUROPSYCHOPHARMACOLOGY

Social Anxiety Disorder

(2017) Falk Leichsenring et al.   NEW ENGLAND JOURNAL OF MEDICINE

Endocannabinoid Signaling in the Control of Social Behavior

(2017) Don Wei et al.   TRENDS IN NEUROSCIENCES

A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum

(2017) A. Musella et al.   Scientific Reports

Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence

(2017) Richard A. Slivicki et al.   BIOLOGICAL PSYCHIATRY

Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience

(2016) Michael Loureiro et al.   BIOLOGICAL PSYCHIATRY

Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling

(2016) V.M. Doenni et al.   BRAIN BEHAVIOR AND IMMUNITY

The CB1Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability

(2016) Aliou B. Gueye et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder

(2016) Tomas Furmark et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD and Beyond

(2016) Vasiliki Michopoulos et al.   NEUROPSYCHOPHARMACOLOGY

Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597

(2016) Julien Matricon et al.   NEUROSCIENCE RESEARCH

Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function

(2016) J. Megan Gray et al.   PSYCHONEUROENDOCRINOLOGY

Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction

(2016) María Rodríguez-Muñoz et al.   Oncotarget

Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling

(2016) Peggy Schneider et al.   Frontiers in Behavioral Neuroscience

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats

(2016) Fernanda F. Peres et al.   Frontiers in Pharmacology

Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome

(2015) Mei Qin et al.   BEHAVIOURAL BRAIN RESEARCH

Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

(2015) John M McPartland et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

(2015) R B Laprairie et al.   BRITISH JOURNAL OF PHARMACOLOGY

Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats

(2015) Antonia Manduca et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

(2015) Matthew W. Elmes et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Fatty Acid Amide Hydrolase C385A Variant Affects Brain Binding of the Positron Emission Tomography Tracer [11C]CURB

(2015) Isabelle Boileau et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety

(2015) J. M. Gray et al.   JOURNAL OF NEUROSCIENCE

Endocannabinoid signalling in reward and addiction

(2015) Loren H. Parsons et al.   NATURE REVIEWS NEUROSCIENCE

Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats

(2015) James Lim et al.   NEUROPSYCHOPHARMACOLOGY

Neurobiological Interactions Between Stress and the Endocannabinoid System

(2015) Maria Morena et al.   NEUROPSYCHOPHARMACOLOGY

Chronic stress and brain plasticity: Mechanisms underlying adaptive and maladaptive changes and implications for stress-related CNS disorders

(2015) Jason Radley et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Cannabidiol as a Potential Treatment for Anxiety Disorders

(2015) Esther M. Blessing et al.   Neurotherapeutics

Reprint of “Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)”

(2015) Luiza Reali Nazario et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Endocannabinoid signaling mediates oxytocin-driven social reward

(2015) Don Wei et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Social Anxiety, Affect, Cortisol Response and Performance on a Speech Task

(2015) Wladyslaw Losiak et al.   PSYCHOPATHOLOGY

FAAH genetic variation enhances fronto-amygdala function in mouse and human

(2015) Iva Dincheva et al.   Nature Communications

Serotonin Synthesis and Reuptake in Social Anxiety Disorder

(2015) Andreas Frick et al.   JAMA Psychiatry

Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats

(2014) Antonia Manduca et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The Reaction to Social Stress in Social Phobia: Discordance between Physiological and Subjective Parameters

(2014) Elisabeth Klumbies et al.   PLoS One

Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial

(2014) Claudine C. Hunault et al.   PSYCHOPHARMACOLOGY

Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain

(2014) Raquel Levin et al.   Frontiers in Pharmacology

Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience

(2013) M.V. Fogaça et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

CB1receptor signaling regulates social anxiety and memory

(2013) Y. Litvin et al.   GENES BRAIN AND BEHAVIOR

Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice

(2013) Mano Aliczki et al.   HORMONES AND BEHAVIOR

Phencyclidine-Induced Social Withdrawal Results from Deficient Stimulation of Cannabinoid CB1 Receptors: Implications for Schizophrenia

(2013) Alexandre Seillier et al.   NEUROPSYCHOPHARMACOLOGY

Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks

(2013) Matthew N. Hill et al.   PSYCHONEUROENDOCRINOLOGY

The neural correlates of emotion-based cognitive control in adults with early childhood behavioral inhibition

(2012) Johanna M. Jarcho et al.   BIOLOGICAL PSYCHOLOGY

The Role of Life Events and HPA Axis in Anxiety Disorders: A Review

(2012) Carlo Faravelli et al.   CURRENT PHARMACEUTICAL DESIGN

Endocannabinoids in Amygdala and Nucleus Accumbens Mediate Social Play Reward in Adolescent Rats

(2012) V. Trezza et al.   JOURNAL OF NEUROSCIENCE

Behavioral Inhibition and Risk for Developing Social Anxiety Disorder: A Meta-Analytic Study

(2012) Jacqueline A. Clauss et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure

(2012) M N Hill et al.   MOLECULAR PSYCHIATRY

Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity

(2012) O Gunduz-Cinar et al.   MOLECULAR PSYCHIATRY

Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans

(2012) Andrea Dlugos et al.   NEUROPSYCHOPHARMACOLOGY

Endocannabinoid system and mood disorders: Priming a target for new therapies

(2012) Vincenzo Micale et al.   PHARMACOLOGY & THERAPEUTICS

Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability

(2012) Lesley D. O'Brien et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids

(2012) E. Puighermanal et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders

(2012) Ana Franky Carvalho et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test

(2012) Valéria Almeida et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats

(2012) Alline Cristina Campos et al.   PSYCHOPHARMACOLOGY

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

(2012) F M Leweke et al.   Translational Psychiatry

Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses

(2011) Arnau Busquets-Garcia et al.   BIOLOGICAL PSYCHIATRY

Cannabinoid Transmission in the Basolateral Amygdala Modulates Fear Memory Formation via Functional Inputs to the Prelimbic Cortex

(2011) H. Tan et al.   JOURNAL OF NEUROSCIENCE

A phenotype of early infancy predicts reactivity of the amygdala in male adults

(2011) C E Schwartz et al.   MOLECULAR PSYCHIATRY

Modulation of the serotonin system by endocannabinoid signaling

(2011) Samir Haj-Dahmane et al.   NEUROPHARMACOLOGY

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

(2011) Mateus M Bergamaschi et al.   NEUROPSYCHOPHARMACOLOGY

Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis

(2011) M.N. Hill et al.   NEUROSCIENCE

Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats

(2011) Natale R. Sciolino et al.   PHARMACOLOGICAL RESEARCH

Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors

(2010) Plinio C. Casarotto et al.   BEHAVIOURAL PHARMACOLOGY

Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes

(2010) Luciano De Petrocellis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

(2010) José Alexandre S Crippa et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats

(2010) N. Realini et al.   NEUROPHARMACOLOGY

Striatal responses to negative monetary outcomes differ between temperamentally inhibited and non-inhibited adolescents

(2010) Sarah M. Helfinstein et al.   NEUROPSYCHOLOGIA

[11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography

(2010) Alan A. Wilson et al.   NUCLEAR MEDICINE AND BIOLOGY

Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay

(2010) Steven G. Kinsey et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Endogenous cannabinoid signaling is essential for stress adaptation

(2010) M. N. Hill et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice

(2010) Tommaso Cassano et al.   PSYCHOPHARMACOLOGY

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression

(2009) Fabrício A. Moreira et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

5-HT1Areceptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats

(2009) Leonardo B.M. Resstel et al.   BRITISH JOURNAL OF PHARMACOLOGY

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

(2009) TV Zanelati et al.   BRITISH JOURNAL OF PHARMACOLOGY

Integrated Cannabinoid CB1 Receptor Transmission within the Amygdala-Prefrontal Cortical Pathway Modulates Neuronal Plasticity and Emotional Memory Encoding

(2009) H. Tan et al.   CEREBRAL CORTEX

Dopamine transporters, D2receptors, and dopamine release in generalized social anxiety disorder

(2009) Franklin R. Schneier et al.   DEPRESSION AND ANXIETY

Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142

(2009) K.S. Sink et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cannabis and anxiety: a critical review of the evidence

(2009) José Alexandre Crippa et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats

(2009) Alexandre Seillier et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic–Pituitary–Adrenal Axis

(2009) Matthew N Hill et al.   NEUROPSYCHOPHARMACOLOGY

Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory

(2009) P. Campolongo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids

(2009) Alline Cristina Campos et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress

(2009) Matthew N. Hill et al.   PSYCHONEUROENDOCRINOLOGY

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond

(2008) Roger G. Pertwee   ADDICTION BIOLOGY

The role of CB1 receptors in psychostimulant addiction

(2008) Joost Wiskerke et al.   ADDICTION BIOLOGY

Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats

(2008) Miriam Schneider et al.   ADDICTION BIOLOGY

Amygdala and Ventrolateral Prefrontal Cortex Function During Anticipated Peer Evaluation in Pediatric Social Anxiety

(2008) Amanda E. Guyer et al.   ARCHIVES OF GENERAL PSYCHIATRY

Neural Response to Self- and Other Referential Praise and Criticism in Generalized Social Phobia

(2008) Karina Blair et al.   ARCHIVES OF GENERAL PSYCHIATRY

Divergent Effects of Genetic Variation in Endocannabinoid Signaling on Human Threat- and Reward-Related Brain Function

(2008) Ahmad R. Hariri et al.   BIOLOGICAL PSYCHIATRY

Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System

(2008) Kay Ahn et al.   CHEMICAL REVIEWS

Cannabinoid and opioid modulation of social play behavior in adolescent rats: Differential behavioral mechanisms

(2008) Viviana Trezza et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Hypothalamic-pituitary-adrenal reactivity in prepubertal children with social phobia

(2008) Dirk van West et al.   JOURNAL OF AFFECTIVE DISORDERS

Increased Serotonin and Dopamine Transporter Binding in Psychotropic Medication-Naive Patients with Generalized Social Anxiety Disorder Shown by 123I- -(4-Iodophenyl)-Tropane SPECT

(2008) N. J. van der Wee et al.   JOURNAL OF NUCLEAR MEDICINE

Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1receptors and fatty acid amide hydrolase

(2008) d. de filippis et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis

(2008) Daniel Marcellino et al.   NEUROPHARMACOLOGY

An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters

(2008) Anna M. Moise et al.   PSYCHOPHARMACOLOGY

A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder

(2007) Karleyton C. Evans et al.   DEPRESSION AND ANXIETY

5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid

(2007) P. Massi et al.   JOURNAL OF NEUROCHEMISTRY

CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour

(2007) T. Rubino et al.   NEUROPHARMACOLOGY

Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice

(2007) David J. Rademacher et al.   NEUROPHARMACOLOGY

Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex

(2007) M.E. Page et al.   NEUROSCIENCE LETTERS